Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Reasons to Bench DraftKings Stock

By Josh Enomoto, InvestorPlace Contributor

If it weren’t for the pandemic, DraftKings stock would be an easy buy. Because of the coronavirus, though, DKNG suffers from too many question marks.

Approach JetBlue Airways Like a ‘Quant’

By Josh Enomoto, InvestorPlace Contributor

Some analysts have discussed the contrarian case for JBLU stock. But is there more to JetBlue Airways than just a good story?

AbbVie Stands to Benefit from Affluenza

By Josh Enomoto, InvestorPlace Contributor

With another wave of coronavirus cases hitting the U.S., AbbVie stock seems a dubious investment. Yet with the acquisition of Allergan and its Botox treatment, ABBV has long-term upside potential.

Some Things to Consider Before Buying Amazon at $3,000

By Josh Enomoto, InvestorPlace Contributor

Incredibly, Amazon stock has just passed the $3,000 level for the first time. Here’s why you can believe in it and why you may want to hold off.

Society Has Shifted Favorably for Remark Holdings

By Josh Enomoto, InvestorPlace Contributor

Political winds have changed favorably for MARK stock, particularly Remark’s AI-powered surveillance business. However, it ultimately remains a gamble.

Load More